Teva Pharmaceutical (Israel) Top Management

TEVA Stock  ILA 6,340  20.00  0.32%   
Teva Pharmaceutical employs about 34 K people. The company is managed by 28 executives with a total tenure of roughly 148 years, averaging almost 5.0 years of service per executive, having 1214.43 employees per reported executive. Analysis of Teva Pharmaceutical's management performance can provide insight into the company performance.
Kaare Schultz  CEO
President, Chief Executive Officer, Director
Amir Elstein  Chairman
Vice Chairman of the Board
  
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Teva Pharmaceutical Industries. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

Teva Pharmaceutical Management Team Effectiveness

The company has return on total asset (ROA) of 0.0363 % which means that it generated a profit of $0.0363 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (0.2414) %, meaning that it generated substantial loss on money invested by shareholders. Teva Pharmaceutical's management efficiency ratios could be used to measure how well Teva Pharmaceutical manages its routine affairs as well as how well it operates its assets and liabilities.

Teva Pharmaceutical Workforce Comparison

Teva Pharmaceutical Industries is currently regarded as top stock in number of employees category among its peers. The total workforce of Health Care industry is at this time estimated at about 59,890. Teva Pharmaceutical totals roughly 34,004 in number of employees claiming about 57% of equities under Health Care industry.
The company has Profit Margin (PM) of (0.16) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of 0.18 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.18.

Teva Pharmaceutical Benchmark Summation

Operator
The output start index for this execution was zero with a total number of output elements of sixty-one. Teva Pharmaceutical Price Series Summation is a cross summation of Teva Pharmaceutical price series and its benchmark/peer.

Teva Pharmaceutical Notable Stakeholders

A Teva Pharmaceutical stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Teva Pharmaceutical often face trade-offs trying to please all of them. Teva Pharmaceutical's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Teva Pharmaceutical's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
Kaare SchultzPresident, Chief Executive Officer, DirectorProfile
Amir ElsteinVice Chairman of the BoardProfile
Sol BarerIndependent Chairman of the BoardProfile
Richard DaniellExecutive Vice President - European CommercialProfile
Mark SabagExecutive Vice President, Chief Human Resources Officer and Global Communications and BrandProfile
Gianfranco NazziExecutive Vice President - International Markets CommercialProfile
Brendan OGradyExecutive Vice President - North America CommercialProfile
Eric DrapeExecutive Vice President - Global OperationsProfile
Hafrun FridriksdottirExecutive Vice President and Presidentident of Global Generics R&DProfile
Eliyahu KalifChief Financial Officer, Executive Vice President, DirectorProfile
David StarkExecutive Vice President, Chief Legal OfficerProfile
Kevin MannixVice President Head of Investor RelationsProfile
Sven DethlefsExecutive Vice President - Global Marketing & PortfolioProfile
Nechemia PeresIndependent DirectorProfile
JeanMichel HalfonStatutory - independent directorProfile
Perry NisenIndependent DirectorProfile
Gerald LiebermanIndependent DirectorProfile
Roberto MignoneIndependent DirectorProfile
Rosemary CraneIndependent DirectorProfile
Ronit SatchiFainaroIndependent DirectorProfile
Kare SchultzCEO PresProfile
Janet VergisIndependent DirectorProfile
Amir WeissVP OfficerProfile
Eli ShaniEx PortfolioProfile
Abbas HussainIndependent DirectorProfile
Kathleen VeitGlobal VPProfile
Deborah GriffinChief Accounting OfficerProfile
Andrew WeilChief Accounting OfficerProfile

About Teva Pharmaceutical Management Performance

The success or failure of an entity such as Teva Pharmaceutical often depends on how effective the management is. Teva Pharmaceutical management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Teva management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Teva management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company was founded in 1901 and is based in Tel Aviv-Yafo, Israel. TEVA PHARMA is traded on Tel Aviv Stock Exchange in Israel.
Please note, the presentation of Teva Pharmaceutical's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Teva Pharmaceutical's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Teva Pharmaceutical's management manipulating its earnings.

Teva Pharmaceutical Workforce Analysis

Traditionally, organizations such as Teva Pharmaceutical use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Teva Pharmaceutical within its industry.

Teva Pharmaceutical Manpower Efficiency

Return on Teva Pharmaceutical Manpower

Revenue Per Employee438.9K
Revenue Per Executive533M
Net Loss Per Employee69.2K
Net Loss Per Executive84M
Working Capital Per Employee158.6K
Working Capital Per Executive192.6M

Complementary Tools for Teva Stock analysis

When running Teva Pharmaceutical's price analysis, check to measure Teva Pharmaceutical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Teva Pharmaceutical is operating at the current time. Most of Teva Pharmaceutical's value examination focuses on studying past and present price action to predict the probability of Teva Pharmaceutical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Teva Pharmaceutical's price. Additionally, you may evaluate how the addition of Teva Pharmaceutical to your portfolios can decrease your overall portfolio volatility.
Money Managers
Screen money managers from public funds and ETFs managed around the world
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Bonds Directory
Find actively traded corporate debentures issued by US companies
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges